Researchers map neural pathways involved in response inhibition

2024 was a difficult year for the pharmaceutical industry; do brighter times lie ahead? Source: Cygnus. Times are tough in the biopharmaceutical industry. Challenges including

Sen­ate Fi­nance Chair Ron Wyden (D-OR) is press­ing Pfiz­er over its tax prac­tices as part of his in­ves­ti­ga­tion in­to how large phar­ma com­pa­nies use sub­sidiaries